TD Cowen analyst Joshua Jennings reiterated a Buy rating and $34.00 price target on Procept BioRobotics Corp (NASDAQ: PRCT).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Procept BioRobotics Corp (PRCT) PT Lowered to $34 at TD CowenFebruary 26, 2026 10:24 AM Form 8-K PROCEPT BioRobotics Corp For: Feb 26February 26, 2026 7:58 AM PROCEPT BioRobotics® Hosts 2026 Investor Day to Detail Multi-year Financial Outlook and Strategic Plan for Long-Term GrowthFebruary 26, 2026 7:55 AM Procept BioRobotics Corp (PRCT) PT Lowered to $28 at Piper SandlerFebruary 26, 2026 7:19 AM Oppenheimer Downgrades Procept BioRobotics Corp (PRCT) to PerformFebruary 26, 2026 6:54 AM Procept BioRobotics Corp (PRCT) PT Lowered to $34 at Wells FargoFebruary 26, 2026 5:58 AM BofA Securities Downgrades Procept BioRobotics Corp (PRCT) to UnderperformFebruary 26, 2026 5:23 AM Form 4 PROCEPT BioRobotics Corp For: Feb 19 Filed by: Nouri AlalehFebruary 25, 2026 4:48 PM Form 4 PROCEPT BioRobotics Corp For: Feb 19 Filed by: Waters KevinFebruary 25, 2026 4:47 PM PROCEPT BioRobotics (PRCT) Misses Q4 EPS by 21c, Offers GuidanceFebruary 25, 2026 4:42 PM Form 8-K PROCEPT BioRobotics Corp For: Feb 25February 25, 2026 4:07 PM